“He Yuan Li Ji” was established as a joint venture between He Yuan Bio (stock code: 688238) and Li Ji Bio, with its core business centered on the “Li Ji Bio” and “Life-ilab” reagent brands.

Select language：

中文

English

Image Name

021-50778506

Image Name
search

Hot Searches：

菜单
headerlogo
搜索
close
Product Center right
Published literature right
Technical Services right
News and Information right
Resource Center right
About Life-ilab right
back返回
Cell biology right
Protein and Immunity right
Nucleic acid electrophoresis right
Staining reagent right
PCR & q-PCR right
Nucleic Acid Synthesis and Extraction right
Microbial culture right
Elisa right
Biochemical reagent right
Common instruments and consumables right
back返回
Literature and Data right
Paper Award right
back返回
Omics Services right
Gene therapy vector right
Genetic manipulation right
Cellular experiment right
Animal experimentation right
Other Special Services right
back返回
New Product Launch right
Corporate News right
Industry News right
Campus Exhibition right
back返回
Case Study Appreciation right
Instruction Manual Download right
COA Inquiry right
Academic Video right
Frequently Asked Questions right
back返回
About Us right
Agent right
Contact Us right
Recruit talented individuals right

NIH-OVCAR-3 (human ovarian adenocarcinoma cells)

copy

One click copying of product information

Product Item Number
Product Specifications
Original price
  • AX07L202
    T25/1 mL
    1100
Download the manual
Manager Zhang (13381793225; same number for WeChat)
  • Product Description
  • Product FAQ
  • COA
  • Product Literature
  • MSDS
  • Operation video

  • Product Description

    NIH-OVCAR-3 (Chinese name: human ovarian adenocarcinoma cells) was established by T. C. Hamilton in 1982. These cells were derived from malignant ascites obtained from a patient with advanced ovarian adenocarcinoma. When 1 × 10⁷ cells were subcutaneously implanted into nude mice, all animals developed tumors within 21 days. NIH-OVCAR-3 cells constitute an appropriate model system for studying drug resistance in ovarian cancer, and their expression of hormone receptors may prove useful for evaluating hormone‑based therapies.

    The cells exhibit a typical epithelial morphology and grow adherently. Species: Human; Cell type: Tumor cell; Tissue origin: Ovarian adenocarcinoma; Tumor type: Ovarian cancer cell.

    Order Information

    Product Name

    Item number

    Specifications

    NIH-OVCAR-3

    AX07L202

    T25/1 mL

    Mode of transportation

    Transport at room temperature/dry ice.

    Related Product Recommendations

    Fetal Bovine Serum (Cat. No.: AC03L055)

    RPMI-1640 medium (containing L-glutamine) (Catalog No.: AC01L064)

    This product is intended solely for scientific research and must not be used for clinical diagnosis, treatment, or any other purposes.


  • Fill in the product batch number for inquiry

    搜索

    • Fill in the product batch number for inquiry

      搜索

      Best Sellers

      recommend1

      Fetal Bovine Serum (FBS)

      EZ Trans Cell Transfection Reagent (High Efficiency)

      Rapid Cell Cryopreservation Solution (Serum-Free, Protein-Free)

      Annexin V-FITC/PI Apoptosis Assay Kit

      D-Luciferin, Potassium Salt (Ultra-Pure)

      Three-color pre-stained protein marker (10–250 kDa)

      EZ ECL pico chemiluminescent solution (ultrasensitive)

      Quick sealing solution (ready-to-use, no rinsing required)

      Ice-free rapid transfer buffer (20X)

      GelRed Nucleic Acid Stain (10,000 × in water)

      < 1234 > proceed page

      Popular Articles

      recommend2

      An Analysis of the Usage Instructions for the Black Mold Removal Reagent

      How to choose the right reagent for removing black mold?

      IF=17.1 | A new breakthrough in cultivated meat: A team from Zhejiang University has created “snowflake pork.”

      IF=31.1 | High-impact Cell Research: A collaborative study by Zhao Chen, Yang Yunlong, and Yihai Cao reveals a novel mechanism by which cold exacerbates venous thrombosis.

      Common Misconceptions and Solutions Regarding Nucleic Acid Removal Reagents in Biological Experiments

      IF=15 | Yuan Xianglin’s team has identified a new clinical targeted therapeutic approach for radiation-induced pulmonary fibrosis.

      IF=44.5 | High-impact publication in Nature Biotechnology: The team led by Chen Jia, Yang Li, and Hong Jiaxu collaboratively developed a virus-like particle delivery system for efficient in vivo cytosine base editing.

      Exploring the Role of Nucleic Acid Removal Reagents in Immunological Research

      IF=14.1 | Lu Yuhua’s team: The GMFG‑TNS4 pathway transmits matrix mechanical signals, promoting pancreatic cancer metastasis.

      IF=37 | High-impact publication in Cell Metabolism: A collaborative study by the Shanghai Institute of Materia Medica and East China University of Science and Technology reveals a novel microbial metabolic modification that drives the pathogenesis of fatty liver disease.

      < 1234...13 > proceed page

      Group Website

      • Contact Information

        Landline phone:021-50778506 
        Business Manager:18616108315

        Business Cooperation/Scholarships:18616108697

        Address:4th Floor, Building 27, Lane 908, Ziping Road, International Medical Park, Pudong New Area, Shanghai

        Email:ztt0005@obiosh.com

      Image Name

      WeChat Official Account

      Image Name

      Online Customer Service 1

      Image Name

      Online Customer Service 2

      Copyright ©2015-2025 Heyuan Liji (Shanghai) Biotechnology Co., Ltd. All Rights Reserved

      SEO tags

      Website Development: Project Name

      kefu Telephone consultation

      18616108315

             WeChat consultation
      微信咨询
      Online Customer Service Apply for use       gotop

      Back to top